Overall Technical outlook

Price Summary

With a -4.26% crash, Glenmark Pharmaceuticals Limited enjoyed a lacklustre day in the stock market.
Glenmark Pharmaceuticals Limited's stock started the year at 1421.2, climbed to a high of 1434.4, fell to 1355.0, and closed -4.26% lower at 1360.7, with 663941 shares traded on 2025-04-25.
The top price for the stock in the last 52 weeks is 1818.15, with the bottom price being 999.65.
Analysts predict that the future price will fluctuate between 1265.0 and 2032.0, with the mean expected price being approximately 1690.9166.

Technicals

Support and Resistance: At 1360.7, the price is supported at 1342.4 and faces resistance at 1399.2. This range suggests that the price for GLENMARK might stay between these levels, with 1342.4 acting as a floor and 1399.2 as a ceiling.
GLENMARK supportResistance 0b160b
Support/Resistance for GLENMARK


Aroon: The current state of the AROON is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
GLENMARK aroon 0b160b
Aroon chart for Glenmark Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position for Glenmark Pharmaceuticals Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
GLENMARK bbands 0b160b
Bolinger Bands chart for Glenmark Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bearish, reinforcing a resistance level that could restrict any upward movement. This resistance indicates that the market may remain under bearish control, with limited potential for gains.
GLENMARK psar 0b160b
Parabolic Stop and Reverse chart for Glenmark Pharmaceuticals Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
GLENMARK stoch 0b160b
Stochastic chart for Glenmark Pharmaceuticals Limited


Tripple Moving Agerage: The current state of the Tripple MOVING AVG is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
GLENMARK trippleSMA 0b160b
Tripple SMA chart for Glenmark Pharmaceuticals Limited


To derive valuable insights from a company's technical performance, it is essential to first understand its fundamentals. This includes its financial health, business model, and market share. Equally important is the industry context, such as competition, consumer demand, and market trends. By examining these aspects together, investors can gain a more comprehensive view of how the company's stock behaves and whether it's aligned with its underlying value.